ArticlebioRxiv : the preprint server for biology2025

IL-1R1 Blockade Boosts CD40 Agonist Immune Responses but Fails to Improve Efficacy or Reduce Hepatotoxicity in Pancreatic Cancer.

Akash Boda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.